...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

I just bought a few shares of Zenith Capital (ZHCLF) on the OTC via the fidelity platform.  The bid ask spread can be very wide....right now it is $.07, 33 cents bid, 40 cents ask.  There are a fair amount of shares on the bid (50k) and the ask (16k).  Volume has been trending up with a few days near or above 100k but the recent average about 7k.

Viable public market?

 

 

 

Share
New Message
Please login to post a reply